Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease
- 1 August 2005
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 77 (15) , 1836-1843
- https://doi.org/10.1016/j.lfs.2005.02.014
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 22 references indexed in Scilit:
- Nigral endothelial dysfunction, homocysteine, and Parkinson's diseaseThe Lancet, 1999
- Blood vessels change in the mesencephalon of patients with Parkinson's diseasePublished by Elsevier ,1999
- Homocysteine and AtherothrombosisNew England Journal of Medicine, 1998
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Rapid Communication: Oxidative Stress Induces Apoptosis in Embryonic Cortical NeuronsJournal of Neurochemistry, 1994
- Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly PopulationJAMA, 1993
- Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.Journal of Clinical Investigation, 1993
- Measurement of total plasma and cerebrospinal fluid homocysteine by fluorescence following high-performance liquid chromatography and precolumn derivatization with o-phthaldialdehydeJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.Journal of Clinical Investigation, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984